About Namrata Sen Chanda
Namrata is an accomplished financial journalist, with nearly a decade of experience. She specializes in interpreting news releases and framing investment strategies, and has worked with some of the leading companies in real estate, banking, insurance, mutual funds, financial research, fintech, and investment education.
After majoring in finance at college, she became a research analyst, tracking economic indicators and analyzing major global economic developments. She then went on to become a contributing author for the Market Realist, focusing on the technology sector.
Namrata has a keen interest in fundamental analysis and is passionate about educating investors about the stock market.
Recent Articles By Namrata Sen Chanda
Buy These Top 4 Undervalued Stocks During the Current Market Rotation
The stock market is currently experiencing a period of investment rotation in which value stocks are getting a lot of attention—at the expense of growth stocks—given their stronger potential to rebound in a recovering economy. Also, rising bond yields and inflationary headwinds aren’t favorable for growth stocks. With the economy threatening a fast-paced recovery, undervalued stocks Takeda Pharmaceutical (TAK), Orange (ORAN), Universal Health Services (UHS), and Ingredion (INGR) should deliver handsome returns. Read on for a closer look at these names.
4 Undervalued Pharmaceutical Stocks That Pay Dividends
The pharmaceutical industry has a reputation for resilience. Many pharma players that garnered noteworthy momentum amid the COVID-19 pandemic are holding strong even as the pandemic is on a decline. That’s because these companies are now focusing on other rare and/or chronic diseases. Four pharmaceutical companies with consistent performance are Pfizer, (PFE), Sanofi (SNY), Bayer AG (BAYRY), and Astellas Pharma (ALPMY). These stocks are also undervalued and pay a healthy dividend. So, how can we not take a closer look at these names? Read on.
3 Gold and Silver Stocks That Wall Street Analysts Love
Investors love gold and silver stocks in times of uncertainty, and so do Wall Street analysts. While daily developments on the economic and stock market fronts do impact the prices of precious metals, long-term investors don’t pay a lot of attention to short-term fluctuations. Given the current, positive, global economic trajectory, Wall Street analysts are optimistic about the upside potential of Agnico Eagle Mines (AEM), Great Panther Mining (GPL), and Iamgold (IAG). Read on for details.
4 Software Stocks to Avoid Like the Plague
Software companies have been under pressure over the past few weeks. While the long-term growth prospects of many software stocks look promising, they are currently somewhat volatile because an expected economic recovery is driving a rotation by investors away from pricey technology stocks and into undervalued turnaround stocks. We think their overvaluation might lead to further declines by Bill.Com Holdings (BILL), Coupa Software (COUP), MongoDB, (MDB), and Lightspeed POS (LSPD) in the near-term. Let’s look closer at their situations.
4 Mid-Cap Mining Stocks to Buy as Gold Rebounds
Gold is currently trading a little above $1,733. However, because inflationary pressure is expected in the near term, economists believe the precious metal will rebound. Therefore, we think it could be a good idea to bet on mid-cap gold mining stocks that have the potential to capitalize on gold’s rebound better than their large-cap counterparts. Thus, B2Gold (BTG), Yamana Gold (AUY), Alamos Gold (AGI), and Harmony Gold Mining Company (HMY) could be good bets to play the precious metal’s comeback.
3 Cryptocurrency Stocks Under $20 to Add to Your Watchlist
Cryptocurrencies have attracted a lot of interest lately thanks to a surge in the prices of bitcoin and ethereum. Considering the misunderstandings and risks surrounding virtual currencies, however, many investors prefer betting on stocks that have exposure to cryptocurrencies rather than taking positions in the currencies directly. Ebang International (EBON), HIVE Blockchain Technologies (HVBTF), and GreenBox POS (GBOX) are three affordable crypto stocks that have huge upside potential. Let’s evaluate them more closely.
4 Stocks to Buy as ESG Investing Gains Traction
Environmental, social and governance (ESG) Investing has gained much momentum over recent years. Investors are now considering adherence to ESG factors in their analysis of the prospects of potential investment targets, and we think a growing awareness of climate change and social and corporate governance issues is sure to boost ESG investing in the future. Microsoft (MSFT), Intel (INTC), Adobe (ADBE), and UnitedHealth (UNH) are four large-cap companies that score highly on ESG factors. So, we believe adding them to one’s portfolio will lead to solid long-term returns. Let’s discuss.
2 Discount Store Stocks to Buy, 2 to Avoid
Discount stores in the United States will likely witness mixed trends as the economy reopens. With reduced COVID-19 fears, shoppers might return to physical stores. However, the federal recovery package and a convalescing job market could prompt consumers to bypass discount stores in favor of traditional retailers. So, investors must pick stocks from this industry judiciously. We believe Dollar Tree (DLTR), and Dollar General (DG) are good bets now, while Five Below (FIVE), and Ollie's Bargain Outlet Holdings (OLLI) should be avoided. Okay, let’s dig in as to why.
4 Mega-cap Stocks That Belong in Your Portfolio
Mega-cap stocks are ideal for conservative investors who wish to earn steady profits without exposing themselves to significant volatility. In the stock market’s current phase of uncertainty, they are the safest bets. Microsoft (MSFT), Alphabet (GOOGL), Facebook (FB), and Johnson & Johnson (JNJ) are four such stocks. They have resilient and diversified business models and the ability to generate positive returns over the long term. Most importantly, we think that having been in business for decades means these giants have experience dealing with the best and worst market phases.